Expression of a naturally occurring angiotensin AT(1) receptor cleavage fragment elicits caspase-activation and apoptosis.

Several transmembrane receptors are documented to accumulate in nuclei, some as holoreceptors and others as cleaved receptor products. Our prior studies indicate that a population of the 7-transmembrane angiotensin type-1 receptor (AT(1)R) is cleaved in a ligand-augmented manner after which the cytoplasmic, carboxy-terminal cleavage fragment (CF) traffics to the nucleus. In the present report, we determine the precise cleavage site within the AT(1)R by mass spectrometry and Edman sequencing. Cleavage occurs between Leu(305) and Gly(306) at the junction of the seventh transmembrane domain and the intracellular cytoplasmic carboxy-terminal domain. To evaluate the function of the CF distinct from the holoreceptor, we generated a construct encoding the CF as an in-frame yellow fluorescent protein fusion. The CF accumulates in nuclei and induces apoptosis in CHO-K1 cells, rat aortic smooth muscle cells (RASMCs), MCF-7 human breast adenocarcinoma cells, and H9c2 rat cardiomyoblasts. All cell types show nuclear fragmentation and disintegration, as well as evidence for phosphotidylserine displacement in the plasma membrane and activated caspases. RASMCs specifically showed a 5.2-fold increase (P < 0.001) in CF-induced active caspases compared with control and a 7.2-fold increase (P < 0.001) in cleaved caspase-3 (Asp174). Poly(ADP-ribose)polymerase was upregulated 4.8-fold (P < 0.001) in CF expressing cardiomyoblasts and colocalized with terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL). CF expression also induces DNA laddering, the gold-standard for apoptosis in all cell types studied. CF-induced apoptosis, therefore, appears to be a general phenomenon as it is observed in multiple cell types including smooth muscle cells and cardiomyoblasts.

[1]  M. Tuncdemir,et al.  The effects of angiotensin-II receptor blockers on podocyte damage and glomerular apoptosis in a rat model of experimental streptozotocin-induced diabetic nephropathy. , 2011, Acta histochemica.

[2]  L. Zentilin,et al.  Stimulation of cardiac apoptosis in ovariectomized hypertensive rats: potential role of the renin–angiotensin system , 2011, Journal of hypertension.

[3]  S. Somlo,et al.  Polycystin-1 C-terminal Cleavage Is Modulated by Polycystin-2 Expression* , 2009, The Journal of Biological Chemistry.

[4]  W. Thomas,et al.  Role of helix 8 in G protein-coupled receptors based on structure–function studies on the type 1 angiotensin receptor , 2009, Molecular and Cellular Endocrinology.

[5]  Raphael Kopan,et al.  Presenilin: RIP and beyond. , 2009, Seminars in cell & developmental biology.

[6]  S. Higashiyama,et al.  Localisation of endothelin B receptor variants to plasma membrane microdomains and its effects on downstream signalling , 2009, Molecular membrane biology.

[7]  C. Koh,et al.  The intracellular domain of amyloid precursor protein induces neuron-specific apoptosis , 2008, Neuroscience Letters.

[8]  M. Caplan,et al.  Polycystin-1 C-terminal tail associates with beta-catenin and inhibits canonical Wnt signaling. , 2008, Human Molecular Genetics.

[9]  C. Albright,et al.  Therapeutic Strategies for Alzheimer’s Disease , 2008, Molecular Neurobiology.

[10]  C. Heizmann,et al.  Calcium-regulated intramembrane proteolysis of the RAGE receptor. , 2008, Biochemical and biophysical research communications.

[11]  J. An,et al.  Regulated intramembrane proteolysis of the low-density lipoprotein receptor-related protein mediates ischemic cell death. , 2008, The American journal of pathology.

[12]  C. Venugopal,et al.  Insulysin Cleaves the APP Cytoplasmic Fragment at Multiple Sites , 2007, Neurochemical Research.

[13]  S. J. Mills,et al.  Cleavage of the angiotensin II type 1 receptor and nuclear accumulation of the cytoplasmic carboxy-terminal fragment. , 2007, American journal of physiology. Cell physiology.

[14]  Qing Yang,et al.  Identification of a putative nuclear localization sequence within ANG II AT(1A) receptor associated with nuclear activation. , 2007, American journal of physiology. Cell physiology.

[15]  H. Krell,et al.  N-Terminal Proteolysis of the Endothelin B Receptor Abolishes Its Ability to Induce EGF Receptor Transactivation and Contractile Protein Expression in Vascular Smooth Muscle Cells , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[16]  S. J. Mills,et al.  Nuclear accumulation of the AT1 receptor in a rat vascular smooth muscle cell line: effects upon signal transduction and cellular proliferation. , 2006, Journal of molecular and cellular cardiology.

[17]  Bulent Ataman,et al.  Wingless Signaling at Synapses Is Through Cleavage and Nuclear Import of Receptor DFrizzled2 , 2005, Science.

[18]  E. Rogaev,et al.  Impas 1 possesses endoproteolytic activity against multipass membrane protein substrate cleaving the presenilin 1 holoprotein , 2004, FEBS letters.

[19]  B. Jugdutt,et al.  Apoptosis and oxidants in the heart. , 2003, The Journal of laboratory and clinical medicine.

[20]  N. Ridgway,et al.  Stimulation of Phosphatidylserine Biosynthesis and Facilitation of UV-induced Apoptosis in Chinese Hamster Ovary Cells Overexpressing Phospholipid Scramblase 1* , 2003, The Journal of Biological Chemistry.

[21]  H. Krell,et al.  The Extracellular N Terminus of the Endothelin B (ETB) Receptor Is Cleaved by a Metalloprotease in an Agonist-dependent Process* , 2002, The Journal of Biological Chemistry.

[22]  L. Kirshenbaum,et al.  Apoptosis in adriamycin cardiomyopathy and its modulation by probucol. , 2001, Antioxidants & redox signaling.

[23]  J. Ellenberg,et al.  A new model for nuclear envelope breakdown. , 2001, Molecular biology of the cell.

[24]  R. Virmani,et al.  Apoptosis and cardiomyopathy. , 2000, Current opinion in cardiology.

[25]  H. Sabbah,et al.  Apoptotic cell death in heart failure. , 2000, Cardiovascular research.

[26]  E. Kojro,et al.  Structural requirements for V2 vasopressin receptor proteolytic cleavage. , 1999, European journal of biochemistry.

[27]  M. Aardema,et al.  Characterization of p53 in Chinese hamster cell lines CHO-K1, CHO-WBL, and CHL: implications for genotoxicity testing. , 1999, Mutation research.

[28]  Alan G. Porter,et al.  Caspase-3 Is Required for DNA Fragmentation and Morphological Changes Associated with Apoptosis* , 1998, The Journal of Biological Chemistry.

[29]  P. Singal,et al.  Adriamycin cardiomyopathy: pathophysiology and prevention , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  C A Beltrami,et al.  Apoptosis in the failing human heart. , 1997, The New England journal of medicine.

[31]  R. Virmani,et al.  Apoptosis in myocytes in end-stage heart failure. , 1996, The New England journal of medicine.

[32]  Z. Darżynkiewicz,et al.  Effect of protease inhibitors on early events of apoptosis. , 1996, Experimental cell research.

[33]  E. Kojro,et al.  Ligand-induced Cleavage of the V2 Vasopressin Receptor by a Plasma Membrane Metalloproteinase (*) , 1995, The Journal of Biological Chemistry.

[34]  J. Sadoshima,et al.  Critical Role of the AT1 Receptor Subtype , 2005 .

[35]  William D. Richardson,et al.  A short amino acid sequence able to specify nuclear location , 1984, Cell.

[36]  You Wang,et al.  Acetylcholine prevents angiotensin II-induced oxidative stress and apoptosis in H9c2 cells , 2010, Apoptosis.

[37]  Arantxa González,et al.  Renin–Angiotensin–Aldosterone System and Cardiomyocyte Apoptosis in Hypertensive Heart Disease , 2009 .

[38]  T. Weimbs,et al.  Polycystin-1, STAT6, and P100 function in a pathway that transduces ciliary mechanosensation and is activated in polycystic kidney disease. , 2006, Developmental cell.

[39]  J. Cook,et al.  Intracellular angiotensin II fusion protein alters AT1 receptor fusion protein distribution and activates CREB. , 2004, Journal of molecular and cellular cardiology.

[40]  Angiotensin II-Induced Nuclear Targeting of the Angiotensin Type 1 (AT 1 ) Receptor in Brain Neurons* , 2022 .